Evidence map›Paper›PMID 34404817›Full record

ArticleScientific reports2021

Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice.

Amélie Bravard, Céline Gérard, Clémence Defois, Bérengère Benoit, Kassem Makki, Emmanuelle Meugnier, Dominique Rainteau, Jennifer Rieusset, Murielle Godet, Hubert Vidal

Open access · goldFull text read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Amélie Bravard *Laboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Céline Gérard *Laboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Clémence DefoisLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Bérengère BenoitLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Kassem MakkiLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Emmanuelle MeugnierLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Dominique RainteauCentre de Recherche Saint-Antoine, INSERM U938, Sorbonne Université, 75012, Paris, France.
Jennifer RieussetLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Murielle GodetLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France.
Hubert VidalLaboratoire CarMeN, INSERM U1060, INRAE U1397, Université de Lyon, Université Claude Bernard Lyon1, 69600, Oullins, France. hubert.vidal@univ-lyon1.fr.
Laboratoire CarMeN · FRSorbonne Université · FRUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the mechanism of action of the antidiabetic drug metformin is still a matter of discussions, it is well accepted that the gut plays an important role. To gain more insights into the mechanisms occurring in the different regions of the intestine, adult male mice were fed a high-fat-high sucrose (HFS) diet for 8 days and treated with metformin by gavage (300 mg/day/kg body weight) during the HFS diet. Metformin counteracted HFS diet-induced overexpression of a network of genes involved in the transport of glucose and fatty acids in the different regions of the small intestine. It also induced beneficial modification of secondary bile acid profile in the caecum, with a reduction of deoxycholic acid and lithocholic acid levels and increased abundance of ursodeoxycholic acid and tauroursodeoxycholic acid, potentially leading to FRX inhibition. In parallel, metformin treatment was associated with specific changes of the microbiota composition in the lumen of the different regions of the intestine. Metformin induced a marked increase in the abundance of Akkermansia muciniphila in the lumen all along the gut and counteracted the effects of HFS diet on the abundances of some bacterial groups generally associated with metabolic disturbances (f-Lachnospiraceae, f-Petostreptococcaceae, g-Clostidium). Therefore, the present work clearly emphasises the role of all the regions of the intestinal tract in the beneficial action of the antidiabetic drug metformin in a prediabetic mouse model.

Indexed as

AnimalsDietary SucroseDiet, Carbohydrate LoadingGastrointestinal MicrobiomeHypoglycemic AgentsIntestinal MucosaIntestinesMaleMetforminMiceMice, Inbred C57BLPrediabetic StateDietary SucroseHypoglycemic AgentsMetformin

Identifiers

PMID34404817
PMCPMC8371110
OpenAlexW3193729266

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.